In addition, DNAM-1 shares the same ligands of the TIGIT and CD96 inhibitory receptors but exhibits opposite functions with respect to them, suggesting a complementary role in the regulation of tumor immunity and inflammatory response [40,41]. Here, TIGIT is linked to neoplasm.